Your SlideShare is downloading. ×
China pharmaceutical intermediate industry market research and investment forecast report
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

China pharmaceutical intermediate industry market research and investment forecast report

8
views

Published on

China pharmaceutical intermediate industry

China pharmaceutical intermediate industry

Published in: Business

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
8
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. By Qianzhan Intelligence Website: http://en.qianzhan.com/ Tel:+86 0755 33220413 Email us: carter@qianzhan.com.cn China Pharmaceutical Intermediate Industry Market Research and Investment Forecast Report Fine chemical engineering has become an important component of global chemical industry. At present, there are more than 100,000 kinds of commercial products in world’s fine chemical products. According to estimation, the total sales revenue of world’s chemical products was 3.2 trillion Yuan, and the global fine chemical products market exceeded 500 billion Yuan in 2009. China fine chemical intermediate industry has grew up and maintained a fast development growth. China’s investment cost, raw materials cost, labor cost and environmental protection cost all have remarkable advantages compared with that of international, which leads the global intermediate industries concentrate in China. Nowadays, the total annual output value of China pharmaceutical, pesticide and dye intermediate industry has exceeded 300 billion Yuan. With the further increase of outsourcing ratio of fine chemical industries, China intermediate industries will maintain a compound average growth rate of 15% within 5 years. From 2010 to 2015, there will be more than 200 billion US dollars patent medical being expired, which will bring huge market space for the development of generic drugs. And the further development of generic drugs will obviously stimulate the demand for intermediate industry. With the growing competition in pharmaceutical intermediate industry, acquisition and capital operation among large enterprises become more and more frequent. The domestic excellent pharmaceutical intermediate manufacturing enterprises pay more attention to the industry market research, especially to the indepth researches on the industry development environment and product buyers. Because of this, a large number of excellent pharmaceutical intermediate brands rise up rapidly, and gradually become leading corporations in pharmaceutical intermediate industry! With Forward’s long-term tracking and collecting market data of pharmaceutical intermediate industry, we roundly and accurately analyze the industry structure system for you from the view of mastering the whole industry. This report mainly focuses on analyzing China pharmaceutical intermediate industry’s market capacity, market size, development speed and competitive situation, depending on macro-prosperity of current pharmaceutical intermediate industry and relying on its production and
  • 2. marketing conditions as well as the demand trend. The report pay more attention to analyze the current market environment and enterprise competitiveness of pharmaceutical intermediate industry; the import and export market of pharmaceutical intermediate industry; the competition analysis of pharmaceutical intermediate industry; the development situation of product market segments of pharmaceutical intermediate industry; the downstream demand situation of pharmaceutical intermediate industry; the leading corporations’ operational conditions in pharmaceutical intermediate industry; as well as the development trend and prospects forecast of pharmaceutical intermediate industry. Meanwhile, with comprehensive and specific first-hand market data over the past 5 years, Forward helps you to grasp the market and development trends of pharmaceutical intermediate industry, so as to win advantages from competition! The most distinctive characteristics of this report is forward-looking and timeliness. Through analyzing forward-looking characteristic of abundant first-hand market data, we deeply and objectively dissect China current pharmaceutical intermediate industry’s overall market capacity, market size, competitive landscape and characteristics of market demand. Furthermore, based on future development tracks and years’ practice experience of pharmaceutical intermediate industry, we conduct prudent analysis and forecast for pharmaceutical intermediate industry’s future development trend. This report helps pharmaceutical intermediate manufacturing enterprises, R&D institutions, marketing enterprises and investment enterprises to precisely grasp current latest developments of the industry. Afterwards, they can make wise operating decisions and define enterprises’ development directions. Here, we would like to express our sincere gratitude to Bureau of Statistics of China, International Information Research Institute, Chinese Academy of International Trade and Economic Cooperation, Tsinghua University Library, Development Research Center of the State Council and Beijing Essence Forward Research Center, for their great support when we conduct this report! Notice: All the market data, especially corporations' ranking data in the report, only for business reference. Please do not take the data for enterprise publicity. Thank you! Or Forward shall not take any responsibility for any consequences! Forward Business Intelligence Co., Ltd. Industry Research Center Research Team of Pharmaceutical Intermediate Industry